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Abstract: Participation in cardiac rehabilitation programs (CRPs)
improves prognosis in patients with coronary artery disease (CAD).
However, not much is known about the effectiveness of CRP in real life.
The aim of this analysis was to identify factors related to the referral to
CRP following hospitalization for CAD and estimate the effectiveness
of the programs in real life.
Medical records of 1061 consecutive patients aged 80 years,
hospitalized due to an acute coronary syndrome or for a myocardial
revascularization procedure in 5 hospitals serving the city and surround-
ing counties, were reviewed and 611 patients were interviewed 6–18
months posthospitalization.
Of 611 patients participating in the interview, 212 (34.7%) were
referred following the hospitalization to a center providing CRP. Age,
hospitalization in a teaching hospital, and index diagnosis were inde-
pendently related to being granted a referral. Among the referred
patients, 86.3% participated in the CRP. Participation in CRP was
related to the lower probability of having high total cholesterol (23%
vs 32%, P< 0.05), fasting glucose (11% vs 18%, P¼ 0.05), HbA1c (8%
vs 16%, P¼ 0.05), and body mass index (27% vs 37%, P< 0.05).
Generally, the effect of the CRP was significant in participants with a
higher education, but not in those with a low education level. Other
factors were not significantly related to the effectiveness of CRP.
This study shows that CRPs are effective, but underused in Poland.
The participant’s education level may influence the effectiveness of
CRP. Therefore, in order to increase the impact of CRP, the content of
such programs should vary depending on the education level of the
participants.
(Medicine 94(32):e1257)
Abbreviations: ACE = angiotesin converting enzyme, BMI = body
mass index, CABG = coronary artery bypass grafting, CAD =
coronary artery disease, CI = confidence interval, CRP = cardiac
rehabilitation program, OR = odds ratio, PCI = percutaneous
coronary intervention.
INTRODUCTION
C ardiovascular disease is the first cause of death world-wide.1 Patients with established coronary artery disease
(CAD) are at high risk of recurrent cardiovascular events. In
spite of the development in pharmacological and invasive
treatment methods, risk factors remain independent predictors
of cardiovascular mortality in CAD patients.2 The conclusion
from the 5-year follow-up survey was that smoking cessation,
providing dietary advice, and ensuring optimal pharmacological
treatment are crucial in reducing mortality in patients who have
suffered from a myocardial infarction.3 Thus, the highest
priority for preventive cardiology was given to patients with
established CAD.4
Participation in the cardiac rehabilitation and education
program was found to be related to an improved lifestyle and
better prognosis following an acute coronary event.4–9 How-
ever, less is known about the contemporary effectiveness of
rehabilitation programs in real life. Moreover, not all patients
participate in such programs.8,10–12 It was shown that the
participation rate in rehabilitation programs following acute
coronary syndromes in Poland is about 20%.10 It was also
suggested that the participation rate may have even been
decreasing in the recent years.13 Therefore, the aim of the
present analysis was to identify factors related to the referral
to cardiac education and rehabilitation programs following
hospitalization due to CAD, as well as to estimate the effec-
tiveness of the programs in real life.
METHODS
Five hospitals with cardiology departments, serving the
city and surrounding districts in the southern part of Poland,
participated in the study. The total population of this area was
about 1,200,000 inhabitants. In each department, the medical
records of consecutive patients hospitalized from January 2010
to April 2012 due to acute myocardial infarction (first or
recurrent, no prior percutaneous coronary intervention [PCI]
or coronary artery bypass grafting [CABG]), unstable angina
(first or recurrent, no prior PCI, CABG, or myocardial infarc-
tion), PCI (first, no prior CABG), or scheduled for CABG (first)
were reviewed, and patients aged 80 years were identified
retrospectively excluding those who had died during their in-
hospital stays and those who were scheduled for CABG com-
bined with valve surgery. If a patient was hospitalized more than
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once within the study period, only the first hospitalization was
accepted as an index event. The medical records of patients
fulfilling the inclusion criteria were analyzed using the stan-
dardized data collection forms.
Participants were invited to take part in the follow-up
examination 6 to 18 months after discharge. Data on demo-
graphic characteristics, personal history of CAD, smoking
status, blood pressure, fasting glucose, plasma lipids, and
prescribed medications were obtained using a standardized data
collection form. Patients’ height and weight were measured in a
standing position without shoes and heavy outer garments using
standard scales with a vertical ruler. Body mass index (BMI)
was calculated according to the following formula: BMI¼ -
weight (kg)/height (m).2 Blood pressure was measured twice, on
the right arm in a sitting position after at least 5 minutes of rest.
For plasma lipid and glucose measurements, a fasting venous
blood sample was taken between 7.30 and 8.30 AM. For the
present report, results of the analyses carried out no later than 4
hours after blood collection were used. All analyses were
performed at one central laboratory. Low-density lipoprotein
(LDL) cholesterol levels were calculated according to Friede-
wald formula. Carbon monoxide in the breath was measured for
biochemical validation of self-reported nonsmoking. The con-
centration of breath carbon monoxide was recorded in parts per
million using the Smokerlyser (Bedfont Scientific, Kent, UK).
We defined the patient as a participant of the cardiac
rehabilitation and education program if he or she participated
in at least half of the planned rehabilitation sessions.
We also calculated the secondary prevention coefficient:
one point was awarded for each risk factor controlled (not
smoking, blood pressure <140/90 mm Hg, LDL cholesterol
<1.8 mmol/L, fasting glucose <7.0 mmol/L, BMI <25 kg/
m2) during the follow-up interview. Additionally, one point
was awarded for taking an antiplatelet agent, one point for
taking an angiotesin-converting enzyme (ACE) inhibitor or a
sartan, and one point for taking a b-blocker in patients with a
history of heart failure or myocardial infarction. Thus, the
secondary prevention coefficient could vary from 1 to 8. The
survey protocol was approved by the Bioethics Committee of
the Jagiellonian University.
Statistical Analysis
Categorical variables were reported as percentages and
continuous variables as means standard deviation. The Pear-
son x2 test was applied to all categorical variables. Normally
distributed continuous variables were compared by using the
Student t test or analysis of variance. Variables without normal
distributions were evaluated using the Mann–Whitney U test or
the Kruskal–Wallis analysis of variance as appropriate. In order
to find factors independently related to the probability of being
granted a referral to the rehabilitation center, stepwise multi-
variate logistic analysis was performed. Assessing the relation
between participation in cardiac rehabilitation and risk factor
control, we constructed 2 multivariable models. Model 1 con-
tained all variables independently related to being granted a
referral to the rehabilitation center, whereas Model 2 (full
model) contained also sex, education, employment, and practice
setting. Finally, we performed subgroup analysis of the relation
between participation in cardiac rehabilitation and the second-
ary prevention coefficient. A 2-tailed P value of <0.05 was
considered as indicating statistical significance. In order to
assess prevalence of risk factors, it was calculated that a sample
of 500 patients, who attended for interview, was sufficient to
estimate prevalences with precision of at least 5%, and with a
confidence interval of 95%. We used the STATISTICA 8.0
software (StatSoft Inc., Tulsa, OK).
RESULTS
The medical records of 1061 patients were reviewed and
included in the analyses. Of 1061 hospitalized patients, 616
(58.1%) took part in the follow-up interview 6 to 18 months
after discharge. Additionally, 5 patients could not decide (did
not remember) whether they had or had not participated in a
rehabilitation or education program following the index hospi-
talization. In consequence, we finally included the data of 611
patients in the present analysis. A possible selection bias in the
formation of this study population was examined by comparing
it with respect to age, sex, risk factors, and the prescription rate
of drugs upon discharge with 450 patients on whom we had no
data concerning participation in a rehabilitation program. These
comparisons did not reveal any statistically significant differ-
ences with respect to all the above factors except for age at the
time of hospitalization (63.6 8.8 years in patients participat-
ing in the interview vs 64.9 10.3 years in nonparticipants;
P< 0.05) and the prescription rate of ACE inhibitors/sartans
upon discharge (88.0% in participants vs 82.9% in nonpartici-
pants; P< 0.05). We also compared the attendance rates
between the index event groups showing a slight but statistically
significant bias (P< 0.05), characterized by a somewhat higher
attendance rate in the PCI group (53.8%, 61.0%, 65.3%, and
50.9% for myocardial infarction, unstable angina, PCI, and
CABG group, respectively).
The mean period of time from the discharge to the follow-
up interview was 1.1 0.2 years. Of 611 patients participating
in the follow-up interview, 212 (34.7%) were referred to a
center providing a cardiac rehabilitation program (CRP). The
characteristics of patients referred and not referred are presented
in Table 1. Age, hospitalization at a teaching hospital, and index
diagnosis were independently related to being granted a referral
(Table 2). Of 611 patients, 184 (30.1%) participated in at least
half of the planned rehabilitation sessions. Among the referred
patients, 86.3% participated in the rehabilitation program.
When we analyzed the whole study, population age, hospital-
ization in a teaching hospital, and index diagnosis were inde-
pendently related to participation in the rehabilitation program
(Table 2). However, when the referral was included in the
statistical model, we found that only 2 factors were indepen-
dently related to participation in the cardiac rehabilitation, that
is, the referral (odds ratio [OR] 2514, confidence intervals [CI]:
330–19,169), and CABG (OR 6.6, CI; 1.12–37.1). In patients
referred to rehabilitation, only 1 factor—CABG as an index
event—was significantly related to participation in a rehabilita-
tion program (OR 8.3, CI: 1.1–64.9).
Participation in the rehabilitation program was related to a
lower mean BMI and fasting glucose, HbA1c, and total choles-
terol (Table 3). A significantly lower proportion of patients who
had participated in a rehabilitation program had high BMI, total
cholesterol, fasting glucose, and HbA1c (Table 4). Participants
of the rehabilitation program were less frequently prescribed
diuretics and calcium antagonists (Table 5); however, the latter
association was not significant in multivariate models (Table 6).
The mean of the secondary prevention coefficient was
5.26 1.32. The coefficient was significantly higher in patients
who had participated in a rehabilitation program (Table 7).
There was significant interaction between participation in the
program and education, that is, the difference was significant in
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participants with a higher education, but not in those with a low
education level (Table 7).
DISCUSSION
In general, our results showed a considerable potential for
the further reduction in cardiovascular risk following hospital-
ization for CAD. Indeed, cardiac rehabilitation and education
programs improve prognosis following an acute coronary
event.3–5,14 Importantly, only 35% of our study participants
were referred for cardiac rehabilitation and only 30% partici-
pated in at least half of the planned rehabilitation sessions.
These numbers are similar to cardiac rehabilitation utilization in
other countries.15–16 Low participation rate could suggest that
the easiest way to improve prognosis after hospitalization for
CAD is to increase access to cardiac rehabilitation and edu-
cation programs. The lower referral rate among older patients
could be partly explained by relatively lower evidence of
benefit in this age group compared to younger patients.17
However, it should be underlined that physical activity ame-
liorates cardiovascular health also in elderly patients.18
Usually, the decision about the referral to a center provid-
ing CRPs is made by the physician whereas the decision about
participation in the program is made by the patient (with or
TABLE 2. Variables Independently Related to the Probability of Being Granted a Referral to the Rehabilitation Center Following
Hospitalization Due to Coronary Artery Disease and to the Probability of Participation in at Least Half of the Planned Rehabilitation
Sessions (N¼611)
Being Referred to the
Rehabilitation Center
Participation in at
Least Half of the Planned
Rehabilitation Sessions
Index event
PCI — —
CABG 10.87 (5.34–22.10) 13.13 (6.36–27.07)
Myocardial infarction 3.29 (1.96–5.53) 3.43 (1.98–5.95)
Unstable angina 2.06 (1.11–3.81) 2.15 (1.12–4.15)
Age (per 10 y) 0.72 (0.58–0.88) 0.76 (0.61–0.93)
Hospitalization in a
teaching hospital
(yes: 1, no: 0)
1.65 (1.05–2.57) 1.70 (1.07–2.70)
CABG¼ coronary artery bypass grafting, PCI¼ percutaneous coronary intervention. Values are odds ratios (95% confidence intervals).
TABLE 1. Characteristics of the Study Group
Referred to the
Rehabilitation Center,
N¼ 212
Not Referred to the
Rehabilitation Center,
N¼ 399 P
Total,
N¼ 611
Age, y 63.1 9.1 65.6 8.6 <0.001 64.7 8.8
Sex
Men, % 70.8 61.7 <0.05 64.8
Women, % 29.2 38.3 35.2
Duration of education, y 12.2 3.3 11.7 3.2 0.10 11.9 3.2
Professionally active, % 26.7 18.6 <0.05 21.3
Index event
Myocardial infarction, % 41.5 31.1 <0.001 34.7
Unstable angina, % 24.5 37.1 32.7
PCI, % 14.2 27.6 22.9
CABG, % 19.8 4.3 9.7
Hospitalization in
Teaching hospital, % 68.9 56.1 <0.01 60.4
Not teaching hospital, % 31.1 43.9 39.6
Practice setting
Hospital outpatient
clinic/cardiologist, %
60.5 50.4 78.9
General practitioner, % 30.2 35.6 0.25 8.6
Private cardiology practice, % 7.0 11.6 10.7
No regular health checkup, % 2.3 2.4 1.8
CABG¼ coronary artery bypass grafting, PCI¼ percutaneous coronary intervention. Values are expressed as mean standard deviation or
proportion of patients.
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without his/her family). We noted that 86.3% of referred
patients participated in the cardiac rehabilitation. Nevertheless,
we looked separately for factors related to referral and to
participation in the rehabilitation and we found similar factors
related to being referred and to participation in the CRP. Indeed,
our results suggest that the decision of the physician is crucial.
Our study showed a considerable selection bias in the profile of
patients who were advised to attend a CRP. Interestingly,
among all index events, the PCI was significantly related to
the lower probability of being referred to a rehabilitation center
(Table 2). Importantly, the potential gain from cardiac rehabi-
litation is considerable irrespective of the diagnostic group.14 In
contrast to the present evidence, results from the Euroaspire III
survey suggested that patients hospitalized for acute myocardial
ischemia (troponine negative) have the lowest probability of
being referred to a rehabilitation center.15 Another important
difference is the relation between the patient’s education level
and the probability of being referred to a rehabilitation center.15
It should, however, be stressed that participants of the Euro-
aspire III survey were hospitalized about 6 to 7 years earlier as
compared to the participants of the present study. Indeed, the
physicians’ approach to cardiac rehabilitation could change
favorably with time. Another explanation could be the different
approach in Poland compared to most other European countries.
In contrast to the Euroaspire III survey, we were able to analyze
the relation between teaching versus regular hospitals and we
could show that patients hospitalized in teaching hospitals were
more frequently referred to rehabilitation centers.
The term cardiac rehabilitation refers to coordinated, multi-
faceted interventions designed to optimize a cardiac patient’s
physical, psychological, and social functioning, in addition to
stabilizing, slowing, or even reversing the progression of the
underlying atherosclerotic processes, thereby reducing morbidity
and mortality.19 Core components of modern cardiac rehabilitation
TABLE 4. Proportions of Patients Participating and Not Participating in Cardiac Rehabilitation With Uncontrolled Risk Factors
6–18 mo After Discharge
Participated in Cardiac
Rehabilitation, N¼ 184
Not Participated in Cardiac
Rehabilitation, N¼ 427 P
Smoking, % 15.8 20.1 0.20
Blood pressure 140/90 mm Hg, % 40.3 44.0 0.41
Blood pressure 130/80 mm Hg, % 64.8 71.4 0.11
Total cholesterol 5.0 mmol/L, % 22.8 31.7 0.03
Total cholesterol 4.5 mmol/L, % 37.7 45.8 0.08
LDL cholesterol 1.8 mmol/L, % 70.1 72.9 0.50
HDL cholesterol <1.0 mmol/L in men
and <1.2 mmol/L in women, %
15.0 18.9 0.26
Triglycerides 1.7 mmol/L, % 27.0 33.0 0.16
Glucose 7.0 mmol/L, % 10.8 17.7 0.05
HbA1c 7.0%, % 8.1 16.2 0.05
Body mass index 25 kg/m2, % 80.5 81.2 0.84
Body mass index 30 kg/m2, % 26.8 36.8 0.02
Waist 80 cm in women or 94 cm in men, % 75.0 78.3 0.38
Waist 88 cm in women or 102 cm in men, % 43.8 49.5 0.20
HDL¼ high-density lipoprotein, LDL¼ low-density lipoprotein. Values are proportions of patients.
Available in 99 patients who participated and 260 patients who not participated in cardiac rehabilitation.
TABLE 3. Relation Between Participation in Cardiac Rehabilitation and the Level of Risk Factors 6–18 mo After Discharge
Participated in Cardiac
Rehabilitation, N¼ 184
Not Participated in Cardiac
Rehabilitation, N¼ 427 P
CO in exhaled air, ppm 3.9 3.6 4.2 4.3 0.65
Systolic blood pressure, mm Hg 134.2 22.6 135.8 21.9 0.31
Diastolic blood pressure, mm Hg 79.0 11.9 80.6 12.7 0.12
Total cholesterol, mmol/L 4.3 1.0 4.6 1.4 0.05
LDL cholesterol, mmol/L 2.3 0.9 2.6 1.1 0.09
HDL cholesterol, mmol/L 1.4 0.4 1.4 0.7 0.63
Triglycerides, mmol/L 1.5 0.8 1.6 1.2 0.33
Glucose, mmol/L 5.7 1.6 6.2 2.1 <0.01
HbA1c, %

6.0 0.7 6.3 1.0 0.01
Body mass index, kg/m2 28.1 4.0 28.9 4.7 0.02
Waist, cm 97.0 11.0 97.5 12.8 0.52
CO¼ carbon monoxide, HDL¼ high-density lipoprotein, LDL¼ low-density lipoprotein. Values are expressed as mean standard deviation.
Available in 99 patients who participated and 260 patients who not participated in cardiac rehabilitation.
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and education programs include comprehensive lifestyle interven-
tion in relation to stopping smoking, making healthy food choices,
and becoming physically active, as well as weight, blood pressure,
lipids and glucose management, and psychosocial support.4,5
Indeed, it was suggested that CRPs should evolve into cardiovas-
cular risk reduction programs instead of being concentrated on
exercises.20
Although we found a significant difference in the secondary
prevention coefficient between those who had and those who had
not participated in cardiac rehabilitation, a greater difference
could be expected. However, about 20% of all Polish participants
of the Euroaspire III survey reported that the rehabilitation
program contained a dietary modification aspect and only 18%
of smoking Polish participants reported that the rehabilitation
program aimed at the cessation of smoking.15 One could expect a
positive correlation between the risk factor control and the quality
of the CRP. Indeed, it seems that there is a room for the further
reduction of cardiovascular risk following hospitalization for
CAD through improvement in the quality of CRPs in Poland.
The significant relationship between the secondary pre-
vention coefficient value and the participation in cardiac reha-
bilitation was shown previously.13 The results of the present
analysis suggest that the effectiveness of cardiac rehabilitation
is significantly greater in higher educated patients. We were not
able to find any other significant interactions. Our results
suggest that the content of the education and rehabilitation
program should depend on the participants’ education and that
more focus on patients with a low education is needed.
TABLE 6. Odds of Noncontrolled Risk Factors and Drugs Use 6–18 mo After Discharge Related to Participation in Cardiac
Rehabilitation
Odds Ratio (95% Confidence Intervals)
Model 1 Model 2
Smoking 0.63 (0.37–1.05) 0.65 (0.38–1.09)
Blood pressure 140/90 mm Hg 0.97 (0.66–1.43) 0.97 (0.66–1.44)
Blood pressure 130/80 mm Hg 0.79 (0.52–1.18) 0.76 (0.50–1.15)
Total cholesterol 5.0 mmol/L 0.60 (0.38–0.96) 0.63 (0.40–1.01)
Total cholesterol 4.5 mmol/L 0.64 (0.43–0.97) 0.66 (0.43–0.99)
LDL cholesterol 1.8 mmol/L 0.74 (0.48–1.14) 0.76 (0.49–1.18)
HDL cholesterol <1.0 mmol/L in men and <1.2 mmol/L in women 0.65 (0.38–1.12) 0.67 (0.39–1.15)
Triglicerydes 1.7 mmol/L 0.64 (0.41–1.00) 0.64 (0.41–1.00)
Glucose 7.0 mmol/L 0.53 (0.29–0.95) 0.52 (0.28–0.95)
HbA1c 7.0% 0.53 (0.23–1.19) 0.53 (0.23–1.19)
Body mass index 25 kg/m2 1.05 (0.64–1.71) 1.01 (0.62–1.66)
Body mass index 30 kg/m2 0.70 (0.46–1.06) 0.71 (0.46–1.08)
Waist 80 cm in women or 94 cm in men 0.86 (0.55–1.35) 0.89 (0.56–1.42)
Waist 88 cm in women or 102 cm in men 0.75 (0.51–1.10) 0.77 (0.52–1.16)
Antiplatelets 1.39 (0.70–2.75) 1.30 (0.65–2.59)
b-blockers 1.03 (0.64–1.67) 1.03 (0.63–1.66)
ACE inhibitors/sartans 0.98 (0.63–1.52) 0.92 (0.58–1.43)
Calcium antagonists 0.78 (0.49–1.23) 0.74 (0.46–1.18)
Diuretics 0.65 (0.44–0.96) 0.65 (0.44–0.98)
Lipid-lowering drugs 1.31 (0.77–2.24) 1.17 (0.68–2.03)
ACE¼ angiotensin-converting enzyme, HDL¼ high-density lipoprotein, LDL¼ low-density lipoprotein. Values are odds ratios (95% confidence
intervals). Model 1—adjusted for age, index event, and hospitalization in a teaching hospital. Model 2—adjusted for age, sex, education, index event,
employment, hospitalization in a teaching hospital, and practice setting.
Available in 99 patients who participated and 260 patients who not participated in cardiac rehabilitation.
TABLE 5. Proportions of Patients Participating and Not Participating in Cardiac Rehabilitation Taking Cardiovascular Drugs
6–18 mo After Discharge
Participated in Cardiac
Rehabilitation, N¼ 184
Not Participated in Cardiac
Rehabilitation, N¼ 427 P
Antiplatelets, % 92.4 89.9 0.34
b-blockers, % 82.6 80.6 0.55
ACE inhibitors/sartans, % 77.7 77.0 0.86
Calcium antagonists, % 18.5 26.2 0.04
Diuretics, % 34.8 46.4 <0.01
Lipid-lowering drugs, % 87.5 83.4 0.19
Values are proportions of patients. ACE¼ angiotensin-converting enzyme.
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It is possible that patients after a severe cardiac event may
be more susceptible to education. Indeed, this could influence
the effects of the CRP. Unfortunately this is not supported by
our results. Indeed, the mean value of secondary prevention
coefficient between CABG and PCI group was not higher
among those who had participated compared to patients who
had not participated in the cardiac rehabilitation. Moreover, no
such phenomenon can be found when patients from myocardial
infarction and unstable angina groups are compared suggesting
that other factors could influence the lack of the rehabilitation
effect in the CABG group.
Limitations of the Study
Interpretations of the results of the present study have some
limitations. First, it is possible that some unrecognized differ-
ences exist between patients who had and those who had not
participated in the cardiac rehabilitation. These differences
could influence the approach to secondary prevention in the
study participants. Second, we were unable to assess the impact
of the differences in the implementation of secondary preven-
tion on the risk of cardiovascular events. Third, our study
participants were not representative of all CAD patients. Partici-
pants were limited to those who had undergone an acute CAD
event or revascularization procedure. Therefore, our results
should not be directly applied to the other patients. Fourth,
information on the referral and participation were obtained from
self-reports. However, an important strength of our analysis is
that it is not just based on abstracted medical record data but
face-to-face interviews and examinations using the same pro-
tocol and standardized methods and instruments, including
central laboratory analyses of lipids and glucose. Therefore,
this analysis provides contemporary information on lifestyle,
risk factor, and therapeutic management for secondary preven-
tion. Fifth, secondary prevention coefficient was calculated as
the number of recommended by the guidelines goals achieved.4
However, the severity of risk factors at baseline beside the
quality of the medical service could have influenced the risk
factors control.21 It should be also underlined that genetic
background could influenced the risk factors control.22–24
Finally, it should be stressed that the differences in risk factor
management at the interview should be interpreted in the
context of selection bias with regard to advice and participation
in cardiac rehabilitation, as it is unclear how far they are related
to the effectiveness of the rehabilitation program or to the
selection of patients in the respective groups.
CONCLUSION
Using the data of consecutive patients hospitalized for
CAD, we were able to show that CRPs seems to be effective and
underused in real life. Our results suggest that the level of
education of participants may influence the effectiveness of
CRPs. Therefore, in order to increase the impact of cardiac
rehabilitation and education programs, it should be considered
to vary the content of such programs depending on the edu-
cation level of the participants. Our results suggest that such
programs should be more focused on patients with the low
education level.
TABLE 7. Mean Values of the Secondary Prevention Coefficient in Subgroups of Patients Participating and Not Participating in
Cardiac Rehabilitation
Participated in
Cardiac Rehabilitation
Not Participated in
Cardiac Rehabilitation P P int.
Age, y
65 5.6 1.4 5.0 1.4 <0.001 0.16
>65 5.5 1.3 5.3 1.2 0.28
Sex
Men 5.7 1.3 5.1 1.3 <0.001 0.15
Women 5.3 1.4 5.2 1.2 0.75
Duration of education, y
11 5.3 1.3 5.1 1.3 0.40 <0.05
>11 5.9 1.3 5.2 1.3 <0.001
Professionally active 5.6 1.2 5.0 1.3 <0.01 0.70
Professionally inactive 5.6 1.4 5.2 1.3 <0.05
Index event
Myocardial infarction 5.9 1.4 5.5 1.4 0.08 0.26
Unstable angina 5.2 1.3 4.8 1.2 0.14
PCI 5.3 1.4 5.0 1.2 0.56
CABG 5.5 1.2 5.6 1.3 0.91
Hospitalization in
Teaching hospital 5.6 1.2 5.2 1.2 0.04 0.41
Not teaching hospital 5.6 1.6 5.0 1.3 0.03
Practice setting
Hospital outpatient clinic/cardiologist 5.6 1.4 5.2 1.3 <0.01 0.47
General practitioner 4.8 1.2 4.9 0.8 0.67
Private cardiology practice 6.1 1.0 5.1 1.3 0.02
No regular health checkup 6.0 2.8 5.1 1.2 0.66
All 5.6 1.3 5.1 1.3 <0.01
CABG¼ coronary artery bypass grafting, PCI¼ percutaneous coronary intervention. Values are means standard deviations.
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